Our local 503A partner, Puramint Compounding Pharmacy, is one example of a pharmacy committed to high-quality production and thorough product testing
Efficacy FDA approval was supported by the Phase III OASIS-4 study, in which patients taking oral Wegovy achieved an average weight loss of 16.6%, compared with 2.7% in the placebo group
Weight management (off-label): Some people may notice weight reduction while treating diabetes, but Rybelsus is not approved for weight loss
Its going to be a larger overall cost, a cost to the system.
While individual results will always vary, research gives us a general idea of what to expect
Your provider can help determine if your nausea and dehydration are normal early-stage adjustments or signals that your dose timing, meal composition, or water intake needs modification